Current role
Chief Scientific
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Chief Scientific
The proxy statement of Karyopharm Therapeutics Inc. reports total compensation of $3,670,884 for Chief Scientific in fiscal 2020, including a base salary of $483,624. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Karyopharm Therapeutics Inc. (KPTI)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Karyopharm Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Richard Paulson CEO, Board Member
- Senior Clinical CEO
- Michael Mano General Counsel
- Kristin Abate Chief Accounting Officer
- Barry E. Greene Board Member
- Chen Schor Board Member
- Christy J Oliger Board Member
- Christy J. Oliger Board Member
- Deepika R. Pakianathan Board Member
- Garen G. Bohlin Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Karyopharm Therapeutics Inc. (KPTI) | Officer and Former President | $483,624 | $3,670,884 |
| 2019 | Karyopharm Therapeutics Inc. (KPTI) | Officer and Former President | $468,500 | $3,020,459 |
Recent activity
No call appearances or filed executive changes recorded yet.